News F3 Platform Biologics Developing Cancer-Preventing Drugs Based on the Work of UChicago Researcher Amifostine has a long history and today could potentially help prevent the development of approximately 40,000 cancer cases each year – the goal of F3 Platform Biologics. Amifostine has traditionally...
Technology Modular Glycopolymer Technology for Antigen-Specific Immune Tolerance This technology achieves significant reduction of anti-drug antibody responses through synthetically mannosylated antigen conjugation that induces antigen-specific humoral tolerance by enhancing hepatic immune tolerance mechanisms. The Unmet Need: Effective mitigation of…
News Translating Research into Products UChicagoTech, the University of Chicago’s Office of Technology and Intellectual Property, recently conducted its second in a series of Translation Events that bring industry experts to campus to advise faculty...
News Midwest Biotech Startup Showcase Spotlights 30+ Breakthrough Innovations from Leading Research Institutions Bringing breakthrough science to the forefront of innovation, the Midwest Biotech Startup Showcase will highlight more than 30 emerging life sciences and biotech ventures from leading research institutions across the...
News Industry Experts Give Biomarker Researchers a ‘Reality Check’ Eileen Dolan, PhD, Professor of Medicine and Chair of Committee on Clinical Pharmacology and Pharmacogenomics at the University of Chicago, says she learned a lot at the Translation Event covering...
News Recombinant Antibody Network Partners with Bristol Myers Squibb to Develop Novel Therapies The Recombinant Antibody Network (RAN), a consortium comprising research groups from UC San Francisco (UCSF), the University of Chicago, and the University of Toronto have expanded a previous research collaboration...
News UChicago Spinout Pyxis Secures $152 Million Series B, Signs Licensing Agreement with Pfizer The University of Chicago spinout Pyxis Oncology has signed a worldwide licensing agreement with Pfizer after raising $152 million to further advance its portfolio of potent biologics. Pyxis in 2019...
News UChicago, Duality Teams to Pitch at 2021 Chicago Venture Summit Several teams from the University of Chicago and Duality – the world’s first accelerator focused exclusively on quantum technologies – pitched at the 2021 Chicago Venture Summit. The venture capital...
News UChicago Professors and Grad Students Among 2021’s Highly Cited Researchers More than 30 professors and graduate students at the University of Chicago were among Clarivate’s annual list of Highly Cited Researchers. The list, which included University of Chicago President, Paul...
News Midwest Biotech Startup Showcase Brings Next Wave of Innovation to San Francisco More than 35 high-growth biotech startups from across the Midwest gathered in San Francisco this week for the Midwest Biotech Startup Showcase, co-hosted by the Polsky Center for Entrepreneurship and...
Technology A Highly-Efficient Platform To Form Vesicular Polymer Nanoparticles For RNA And Protein Payload Delivery Polymersomes are a type of nanoscale vesicle made from block copolymers and can encapsulate a variety of therapeutic agents including proteins and nucleic acids. These nanovesicles are assembled at room…
Technology Engineered Flt3L Variants For Antigen Tolerance Induction Engineered recombinant fusion of the dendritic cell growth factor Flt3L to serum albumin to modulate the antigen-presenting compartment and bias it toward tolerance particularly against therapeutic proteins. The Unmet Need:…
